← All Absci CORP filings

Absci CORP DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
ABSI
Absci CORP
DEFA14A: ABSCI Corporation Files Definitive Proxy Statement
ABSCI Corporation has filed a definitive proxy statement with the SEC, indicating upcoming corporate actions requiring shareholder votes.
NASDAQ
ABSI
Absci CORP
DEF: Absci Aims to Redefine Biologics Creation with AI, Eyes Clinical-Stage Transformation
Absci leverages generative AI to accelerate biologics creation, advancing internal pipeline and strategic partnerships towards becoming a clinical-stage biotech company.
NASDAQ
ABSI
Absci CORP
DEFA14A: ABSCI Corporation Files Definitive Proxy Statement
ABSCI Corporation has filed a definitive proxy statement with the SEC, indicating upcoming shareholder actions.
NASDAQ
ABSI
Absci CORP
DEF 14A: Absci Corporation Aims to Revolutionize Drug Discovery with AI: 2024 Annual Meeting Focuses on Innovation and Strategic Partnerships
Absci Corporation's 2024 Annual Meeting highlights the company's AI-driven approach to drug discovery, aiming to accelerate therapeutic development and improve patient outcomes.